Spruce Biosciences BLA filing for rare disease drug on track for 2026

Go back to Spruce Biosciences BLA filing for rare disease drug on track for 2026
(NASDAQ: SPRB) Delayed: 59.09 +1.16 (2.00%)
Previous Close $57.93    52 Week High
Open $57.39    52 Week Low
Day High $60.51    P/E N/A 
Day Low $56.60    EPS
Volume 186,655